A Pennsylvania appeals court rejected Johnson & Johnson’s bid to challenge expert testimony in a trial over claims that its antipsychotic drug Risperdal caused a boy to grow female breasts, which resulted in a $1.75 million verdict against the drug company and its subsidiary Janssen Pharmaceuticals. The verdict was later reduced after a trial judge agreed that the plaintiff was bound by Maryland law, which limits noneconomic damages to $680,000. The three-judge Superior Court panel rejected Janssen’s arguments that plaintiffs expert Dr. Francesco DeLuca had improperly relied on an 8-year-old photograph of plaintiff Nicholas Murry to determine he had gynecomastia, ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.